We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
DNA Electronics CEO to Address Scripps “Future of Genomic Medicine” Conference
News

DNA Electronics CEO to Address Scripps “Future of Genomic Medicine” Conference

DNA Electronics CEO to Address Scripps “Future of Genomic Medicine” Conference
News

DNA Electronics CEO to Address Scripps “Future of Genomic Medicine” Conference

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "DNA Electronics CEO to Address Scripps “Future of Genomic Medicine” Conference"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

DNA Electronics Ltd. today announces that DNA Electronics Chairman and CEO Professor Chris Toumazou FRS will be an invited speaker at the upcoming “The Future of Genomic Medicine V” conference presented by the Scripps Translational Science Institute (March 1-2 2012, La Jolla, California).

Professor Toumazou will be speaking as part of the “Hot Topics in Genomic Medicine” track, addressing a key presentation on “DNA Transistors and Handheld Sequencing” to the conference audience of physicians, healthcare professionals, human geneticists, genomic scientists and researchers. Prof. Toumazou’s presentation will explore how scalable semiconductor solutions for real-time nucleic acid detection can enable faster, simpler and more cost-effective DNA analysis platforms.

The fifth Future of Genomic Medicine conference will focus on the extraordinary advances that are occurring in the field, which include whole genome and exome sequencing, pharmacogenomics, and advances in cancer treatment as an outgrowth of genomics. The 2012 conference features a two-day curriculum from a renowned faculty representing the country’s leading institutions, headed by Director of Scripps.

Advertisement